Lakefront Biotherapeutics NV current report, Q2 FY2022

Business Context and Reporting Period

This Form 6-K is filed by Galapagos NV (not Lakefront Biotherapeutics NV as indicated in metadata) for the month of May 2022. The filing serves to incorporate by reference a press release dated May 6, 2022, which is attached as Exhibit 99.1. The registrant is a foreign private issuer based in Mechelen, Belgium, and files annual reports on Form 20-F.

Financial Metrics

The provided filing text does not contain specific financial data. It acts as a cover document to distribute a press release. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this text.

Material Changes

The filing text does not describe specific material changes to financial position or operations. It solely references the issuance of a press release on May 6, 2022, the content of which is not included in the provided text.

Guidance, Outlook, and Risks

The filing text does not provide management commentary, guidance, outlook, or specific risk factors. It notes that the information in the attached press release is incorporated by reference into various Registration Statements (Forms F-3 and S-8).

Key Facts for Investor Verification

  • Company Identity: Verify that the filing pertains to Galapagos NV, not Lakefront Biotherapeutics NV.
  • Content Source: The substantive information regarding the May 6, 2022 event is located in the attached Exhibit 99.1 (Press Release), which is not included in the provided text.
  • Registration Statements: The press release information is incorporated into multiple active registration statements (File Nos. 333-230639 and various S-8 filings).
  • Financial Data: No financial metrics are available in this specific document; investors must consult the company's most recent Form 20-F or the full press release for financial details.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.